Pharmaceutical research and development company Serina Therapeutics has partnered with the Scripps Research Institute to jointly develop polymer-antibody drug conjugates (Polymer-ADCs). Terms and financial details of the deal have not ...
Tags: Polymer-Antibody Drug, Medicine
KU Leuven and FIT Biotech have reached a global license and partnership agreement for the development of novel immunotherapeutics leveraging FIT Biotech's gene transport unit (GTU) technology for transient in vivo expression of monoclonal ...
Daiichi Sankyo Company has decided to expand its collaborative drug discovery program with universities and research institutions based in Japan, Take a New challenge for Drug diScovery (TaNeDS) Global Program, to Germany, Switzerland and ...
Tags: Daiichi Sankyo, Medicine
The US FDA has approved Janssen Biotech's Simponi ARIA (golimumab) for infusion to treat moderately to severely active rheumatoid arthritis (RA). Simponi ARIA is the only fully-human anti-tumor necrosis factor (TNF)-alpha infusible ...
Israeli Drug discovery company Compugen is developing a Predictive Structural Biology (PSB) infrastructure platform to identify the functional interaction sites of proteins, which are useful in the rational design of novel drugs. Intended ...
Novartis has received an approval from the European Commission for its Lucentis (ranibizumab) to treat patients with visual impairment due to choroidal neovascularization (CNV) secondary to pathologic myopia (myopic CNV). Lucentis is a ...
US-based Ambrx and China-based Zhejiang Medicine have collaborated to develop and commercialize ARX788, an antibody drug conjugate (ADC) targeting Her2-positive breast cancer. As per the deal, both the companies will advance the product ...
Genmab and ADC Therapeutics have partnered to co-develop a new antibody-drug conjugate (ADC) product conjugate to treat multiple cancer indications. The collaboration will integrate Genmab's high-affinity fully human antibody targeting ...
Tags: Genmab, ADC Partner
Daiichi Sankyo Company has launched Pralia subcutaneous injection 60mg syringe (generic name denosumab) for the treatment of osteoporosis, following its manufacturing and marketing approval in Japan. Designed to specifically inhibit an ...
Tags: Daiichi Sankyo, Syringe
Speciality pharmaceutical and diagnostic company, Prometheus is set to begin Proclivity02, a study that compares the sequence of Proleukin (High Dose Interleukin-2 (HD IL-2) therapy at multi centers in US for metastatic melanoma (mM). ...
Lpath has won a US patent covering methods of using monoclonal antibodies for the treatment and prevention of ocular conditions, including wet age-related macular degeneration (AMD). The patent includes the use of monoclonal antibodies, ...
Alethia Biotherapeutics has gained US patent for methods of treating carcinomas with antibodies targeting the region of secreted clusterin (sCLU) responsible for promoting epithelial-to-mesenchymal transition (EMT). The company along with ...
Tags: Alethia, US Patent, Cancer Treatment Methods
Sanofi and Regeneron Pharmaceuticals have announced the commencement of patient enrollment in two Phase 3 rheumatoid arthritis (RA) trials, the COMPARE and ASCERTAIN trials, with Sarilumab. The first fully human monoclonal antibody ...
Sanofi Pasteur and KaloBios Pharmaceuticals have announced the issuance of FDA fast track designation for novel biologic candidate KB001A targetting Pseudomonas Aeruginosa (Pa). An antibody fragment KB001A is developed against Pa that ...
Tags: Sanofi Pasteur, KB001A
Quest Diagnostics, a provider of diagnostic information services, introduced new blood tests, designed for the early diagnosis of rheumatoid arthritis (RA). The company claimed that RA is an autoimmune disorder and can cause debilitating ...
Tags: blood tests, Medicine